Urizia 6Mg/0.4Mg With 30 Tablets (Solifenacin/Tamsulosin)

Category

Medications for the treatment of urological disorders

Line

Treatment of urinary symptoms

Brand

Urizia

Molecule

Solifenacin/Tamsulosin

Presentation

30 Tablets

Laboratory

Asofarma

Indications

Urizia is indicated for the treatment of overactive bladder symptoms, including urinary urgency, urinary frequency, and urge incontinence. It is also used in patients with lower urinary tract obstruction symptoms, such as difficulty initiating urination, weak urinary stream, and a feeling of incomplete bladder emptying. The combined use of Solifenacin and Tamsulosin allows for a comprehensive approach to urinary symptoms, improving the quality of life for patients with urological disorders.

Composition

Each Urizia tablet contains: Solifenacin 6 mg and Tamsulosin 0.4 mg as active ingredients, plus excipients.

Contraindications

Urizia is contraindicated in patients with hypersensitivity to any of the components of the formula. It should not be used in patients with urinary retention, narrow-angle glaucoma, or in those with a history of gastrointestinal obstruction. Furthermore, it is contraindicated in cases of severe hepatic impairment and in patients taking certain medications that interact with Solifenacin and Tamsulosin.

Precautions

Caution is recommended in patients with a history of cardiovascular problems, mild to moderate kidney or liver disease, and in those who have difficulty swallowing tablets. It is important to monitor patients who experience symptoms of hypotension or dizziness, as well as those who use other medications that could potentially interact with the therapy.

Storage

Store in a cool, dry place, at a temperature between 15 and 30 degrees Celsius. Keep out of reach of children.

Prescription required.

Consult your doctor.